Found: 16
Select item for more details and to access through your institution.
Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT).
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 10, p. 324, doi. 10.2196/38718
- By:
- Publication type:
- Article
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 837, doi. 10.1007/s40121-020-00334-1
- By:
- Publication type:
- Article
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 4, p. 743, doi. 10.3201/eid2804.211907
- By:
- Publication type:
- Article
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32527-2
- By:
- Publication type:
- Article
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14057, doi. 10.3390/ijms232214057
- By:
- Publication type:
- Article
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 487, doi. 10.3390/vaccines12050487
- By:
- Publication type:
- Article
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1004045
- By:
- Publication type:
- Article
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.863039
- By:
- Publication type:
- Article
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
- Published in:
- Infection, 2020, v. 48, n. 4, p. 631, doi. 10.1007/s15010-020-01461-0
- By:
- Publication type:
- Article
Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2.
- Published in:
- Peritoneal Dialysis International, 2022, v. 42, n. 1, p. 100, doi. 10.1177/08968608211055631
- By:
- Publication type:
- Article
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1166589
- By:
- Publication type:
- Article
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2475, doi. 10.3390/v14112475
- By:
- Publication type:
- Article
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 2000, doi. 10.1093/cid/ciab555
- By:
- Publication type:
- Article
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
- Published in:
- HIV Medicine, 2022, v. 23, n. 5, p. 558, doi. 10.1111/hiv.13202
- By:
- Publication type:
- Article
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.
- Published in:
- Oncology, 2022, v. 100, n. 7, p. 392, doi. 10.1159/000524894
- By:
- Publication type:
- Article
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07347-w
- By:
- Publication type:
- Article